SAB Biotherapeutics Inc (SABSW) stock news · $860.0K cap
SAB Biotherapeutics Inc (SABSW) warrant listed on NASDAQ.
This SABSW news page leads with what SAB Biotherapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for SABSW yet. We will not pad this page with generic market recap.
Latest reported SABSW revenue for 2025-12-31 was $0. Net income was $13.3M. Revenue was down 100.0% from 2023-12-31 to 2025-12-31. SABSW currently screens at market cap $860.0K.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SABSW stock page; for the tape open the quote page.
SABSW stock news FAQ
What is SABSW's latest net income?
Latest cached SAB Biotherapeutics Inc (SABSW) net income was $13.3M. Statements: https://lician.com/financials/sabsw
What is SABSW's market cap?
SAB Biotherapeutics Inc (SABSW) market cap is $860.0K on the latest cached fundamentals snapshot.
Where is SABSW listed?
SAB Biotherapeutics Inc (SABSW) warrant is listed on NASDAQ.
Where is SABSW stock news listed?
Cached stock news for SAB Biotherapeutics Inc (SABSW) is listed at https://lician.com/news/sabsw. Filings: https://lician.com/sec/sabsw
Not investment advice.